CorMedix (NYSEMKT:CRMD) Director Matthew Duffy sold 30,000 shares of the company’s stock on the open market in a transaction dated Thursday, June 4th. The shares were sold at an average price of $6.48, for a total value of $194,400.00. Following the sale, the director now directly owns 53,223 shares in the company, valued at approximately […]
The post CorMedix Director Matthew Duffy Sells 30,000 Shares (CRMD) appeared first on WKRB News.